TCM
PLSE icon

TD Capital Management’s Pulse Biosciences PLSE Stock Holding History

TD Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40
Closed -$549 – 901
2025
Q4 		$549 Hold
40
– – ﹤0.01% 703
2025
Q3 		$708 Hold
40
– – ﹤0.01% 640
2025
Q2 		$604 Hold
40
– – ﹤0.01% 645
2025
Q1 		$644 Buy
+40
New +$746 ﹤0.01% 580

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

TD Capital Management's PLSE Position: Q1 2026 in Review

TD Capital Management sold out of Pulse Biosciences (PLSE) in Q1 2026, closing a stake of 40 shares — an estimated $549 sold.

TD Capital Management first reported a position in PLSE in Q1 2025 and held it in 4 quarters. The position peaked at $708 in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • TD Capital Management reported no remaining Pulse Biosciences position as of Q1 2026 after selling out during the quarter.
  • TD Capital Management sold 40 Pulse Biosciences shares in Q1 2026, an estimated $549.
  • TD Capital Management first reported a position in Pulse Biosciences in Q1 2025 and held it in 4 quarters.
  • TD Capital Management's Pulse Biosciences position peaked at $708 in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.